Resilience Training for Work-related Stress in Employees and the Influence of the Lecture Format on Training Success
Resilience Training With Mobile Heart Rate Variability Biofeedback for Work-related Stress in White-collar Employees and the Influence of the Lecture Format (Digital vs. Live) on Training Success
1 other identifier
interventional
90
1 country
1
Brief Summary
A study to analyze the psychophysiological effects of a preventative, 4-week resilience training with mobile heart rate variability biofeedback (HRV-BfB) in a workplace setting and the influence of the lecture format (digital vs. live) on the training success.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2016
CompletedFirst Submitted
Initial submission to the registry
May 18, 2021
CompletedFirst Posted
Study publicly available on registry
May 21, 2021
CompletedJune 8, 2021
June 1, 2021
3 months
May 18, 2021
June 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
COPSOQ personal burnout after the intervention
Personal burnout was assessed with the adapted German long version of the Copenhagen Psychosocial Questionnaire (COPSOQ) at T1. Six questions were answered on an ordinal scale, transformed to values ranging between 0=minimum value and 100=maximum value (higher values indicate a more severe burnout symptomatology) and averaged to obtain a scale score (0-100).
After the 4-week intervention (T1)
Secondary Outcomes (12)
Change in the COPSOQ scale personal burnout between baseline (T0) and 4-week follow-up (T2)
Baseline (T0) and 4-week follow-up (T2)
Change in the COPSOQ scale subjective general health between baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
Baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
Change in the COPSOQ scale work-privacy conflict between baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
Baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
Change in the COPSOQ scale behavioral stress symptoms between baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
Baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
Change in the COPSOQ scale cognitive stress symptoms between baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
Baseline (T0), after the 4-week intervention (T1), and 4-week follow-up (T2)
- +7 more secondary outcomes
Study Arms (3)
Resilience training with mobile HRV-BfB based on an e-learning approach (with digital lectures)
EXPERIMENTALResilience training with mobile HRV-BfB based on a blended learning approach (with live lectures)
EXPERIMENTALWaitlist controls
NO INTERVENTIONInterventions
A 4-week resilience training with a mobile HRV-BfB device. Participants received access to three online lectures at the start of the first, third, and forth training week (each lasting 60 minutes) to receive a theoretical base on resilience and to learn how to exercise with the HRV-BfB device. Participants were asked to exercise three times a day for 5 minutes in their occupational and leisure time with the HRV-BfB device.
A 4-week resilience training with a mobile HRV-BfB device. Participants attended three live lectures at the start of the first, third, and forth training week (each lasting 90 minutes) to receive a theoretical base on resilience and to learn how to exercise with the HRV-BfB device. Participants were asked to exercise three times a day for 5 minutes in their occupational and leisure time with the HRV-BfB device.
Eligibility Criteria
You may qualify if:
- Written informed consent
- Employees of the company at which the study is conducted
You may not qualify if:
- Implanted pacemaker
- Medically diagnosed heart failure or arrhythmia
- Medically prescribed cardiac drugs (e.g., beta-blockers, diuretics, ACE inhibitors, calcium channel blockers, or antiarrhythmic agents)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arcim Institute
Filderstadt, Baden-Wurttemberg, 70794, Germany
Related Publications (1)
Vagedes J, Szoke H, Islam MOA, Sobh M, Kuderer S, Khazan I, Vagedes K. Mobile Heart Rate Variability Biofeedback for Work-Related Stress in Employees and the Influence of Instruction Format (Digital or Live) on Training Outcome: A Non-Randomized Controlled Trial. Appl Psychophysiol Biofeedback. 2025 Mar;50(1):79-93. doi: 10.1007/s10484-024-09671-0. Epub 2024 Nov 1.
PMID: 39485585DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jan Vagedes
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2021
First Posted
May 21, 2021
Study Start
October 4, 2016
Primary Completion
December 19, 2016
Study Completion
December 19, 2016
Last Updated
June 8, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The data will be made available upon publication for a duration of three months.
- Access Criteria
- The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.
Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.